Clinical trial
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation (CORE-HCT): A Prospective Multicenter Observational Study
NCT07349498 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation (CORE-HCT): A Prospective Multicenter Observational Study
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 1, 2026
- Completion date
- December 31, 2036
- Enrollment
- 10,000 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular events, hematopoietic stem cell transplantation, transplant complication